The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Lanreotide-Global Market Insights and Sales Trends 2024
Synopsis
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome
The global Lanreotide market size is expected to reach US$ 1506.5 million by 2029, growing at a CAGR of 1.1% from 2023 to 2029. The market is mainly driven by the significant applications of Lanreotide in various end use industries. The expanding demands from the Hospital and Pharmacy, are propelling Lanreotide market. 60 mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 90 mg segment is estimated at % CAGR for the next seven-year period.
Lanreotide is a somatostatin analog primarily used to treat acromegaly and neuroendocrine tumors. Its efficacy in controlling hormone secretion and tumor growth has driven market growth. The rising prevalence of acromegaly and neuroendocrine tumors, coupled with the drug's extended duration of action, contributes to its popularity. However, competition from other somatostatin analogs and the need for individualized treatment plans may pose challenges. The market is relatively small compared to other therapeutic areas. Despite challenges, the Lanreotide market presents potential for expansion as healthcare providers prioritize personalized and targeted therapies for acromegaly and neuroendocrine tumors, creating opportunities for further development and investment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lanreotide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lanreotide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lanreotide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lanreotide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lanreotide covered in this report include IPSEN. etc.
The global Lanreotide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
IPSEN
Global Lanreotide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lanreotide market, Segment by Type:
60 mg
90 mg
120 mg
Global Lanreotide market, by Application
Hospital
Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Lanreotide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Lanreotide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome
The global Lanreotide market size is expected to reach US$ 1506.5 million by 2029, growing at a CAGR of 1.1% from 2023 to 2029. The market is mainly driven by the significant applications of Lanreotide in various end use industries. The expanding demands from the Hospital and Pharmacy, are propelling Lanreotide market. 60 mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 90 mg segment is estimated at % CAGR for the next seven-year period.
Lanreotide is a somatostatin analog primarily used to treat acromegaly and neuroendocrine tumors. Its efficacy in controlling hormone secretion and tumor growth has driven market growth. The rising prevalence of acromegaly and neuroendocrine tumors, coupled with the drug's extended duration of action, contributes to its popularity. However, competition from other somatostatin analogs and the need for individualized treatment plans may pose challenges. The market is relatively small compared to other therapeutic areas. Despite challenges, the Lanreotide market presents potential for expansion as healthcare providers prioritize personalized and targeted therapies for acromegaly and neuroendocrine tumors, creating opportunities for further development and investment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lanreotide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lanreotide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lanreotide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lanreotide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lanreotide covered in this report include IPSEN. etc.
The global Lanreotide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
IPSEN
Global Lanreotide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lanreotide market, Segment by Type:
60 mg
90 mg
120 mg
Global Lanreotide market, by Application
Hospital
Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Lanreotide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Lanreotide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Lanreotide Market Overview
1.1 Lanreotide Product Overview
1.2 Lanreotide Market Segment by Type
1.2.1 60 mg
1.2.2 90 mg
1.2.3 120 mg
1.3 Global Lanreotide Market Size by Type
1.3.1 Global Lanreotide Market Size Overview by Type (2018-2029)
1.3.2 Global Lanreotide Historic Market Size Review by Type (2018-2023)
1.3.3 Global Lanreotide Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Lanreotide Sales Breakdown by Type (2018-2023)
1.4.2 Europe Lanreotide Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Lanreotide Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Lanreotide Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Lanreotide Sales Breakdown by Type (2018-2023)
2 Global Lanreotide Market Competition by Company
2.1 Global Top Players by Lanreotide Sales (2018-2023)
2.2 Global Top Players by Lanreotide Revenue (2018-2023)
2.3 Global Top Players by Lanreotide Price (2018-2023)
2.4 Global Top Manufacturers Lanreotide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Lanreotide Market Competitive Situation and Trends
2.5.1 Lanreotide Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Lanreotide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lanreotide as of 2022)
2.7 Date of Key Manufacturers Enter into Lanreotide Market
2.8 Key Manufacturers Lanreotide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Lanreotide Status and Outlook by Region
3.1 Global Lanreotide Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Lanreotide Historic Market Size by Region
3.2.1 Global Lanreotide Sales in Volume by Region (2018-2023)
3.2.2 Global Lanreotide Sales in Value by Region (2018-2023)
3.2.3 Global Lanreotide Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Lanreotide Forecasted Market Size by Region
3.3.1 Global Lanreotide Sales in Volume by Region (2024-2029)
3.3.2 Global Lanreotide Sales in Value by Region (2024-2029)
3.3.3 Global Lanreotide Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Lanreotide by Application
4.1 Lanreotide Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Lanreotide Market Size by Application
4.2.1 Global Lanreotide Market Size Overview by Application (2018-2029)
4.2.2 Global Lanreotide Historic Market Size Review by Application (2018-2023)
4.2.3 Global Lanreotide Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Lanreotide Sales Breakdown by Application (2018-2023)
4.3.2 Europe Lanreotide Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Lanreotide Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Lanreotide Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Lanreotide Sales Breakdown by Application (2018-2023)
5 North America Lanreotide by Country
5.1 North America Lanreotide Historic Market Size by Country
5.1.1 North America Lanreotide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Lanreotide Sales in Volume by Country (2018-2023)
5.1.3 North America Lanreotide Sales in Value by Country (2018-2023)
5.2 North America Lanreotide Forecasted Market Size by Country
5.2.1 North America Lanreotide Sales in Volume by Country (2024-2029)
5.2.2 North America Lanreotide Sales in Value by Country (2024-2029)
6 Europe Lanreotide by Country
6.1 Europe Lanreotide Historic Market Size by Country
6.1.1 Europe Lanreotide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Lanreotide Sales in Volume by Country (2018-2023)
6.1.3 Europe Lanreotide Sales in Value by Country (2018-2023)
6.2 Europe Lanreotide Forecasted Market Size by Country
6.2.1 Europe Lanreotide Sales in Volume by Country (2024-2029)
6.2.2 Europe Lanreotide Sales in Value by Country (2024-2029)
7 Asia-Pacific Lanreotide by Region
7.1 Asia-Pacific Lanreotide Historic Market Size by Region
7.1.1 Asia-Pacific Lanreotide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Lanreotide Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Lanreotide Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Lanreotide Forecasted Market Size by Region
7.2.1 Asia-Pacific Lanreotide Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Lanreotide Sales in Value by Region (2024-2029)
8 Latin America Lanreotide by Country
8.1 Latin America Lanreotide Historic Market Size by Country
8.1.1 Latin America Lanreotide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Lanreotide Sales in Volume by Country (2018-2023)
8.1.3 Latin America Lanreotide Sales in Value by Country (2018-2023)
8.2 Latin America Lanreotide Forecasted Market Size by Country
8.2.1 Latin America Lanreotide Sales in Volume by Country (2024-2029)
8.2.2 Latin America Lanreotide Sales in Value by Country (2024-2029)
9 Middle East and Africa Lanreotide by Country
9.1 Middle East and Africa Lanreotide Historic Market Size by Country
9.1.1 Middle East and Africa Lanreotide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Lanreotide Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Lanreotide Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Lanreotide Forecasted Market Size by Country
9.2.1 Middle East and Africa Lanreotide Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Lanreotide Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 IPSEN
10.1.1 IPSEN Company Information
10.1.2 IPSEN Introduction and Business Overview
10.1.3 IPSEN Lanreotide Sales, Revenue and Gross Margin (2018-2023)
10.1.4 IPSEN Lanreotide Products Offered
10.1.5 IPSEN Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Lanreotide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Lanreotide Industrial Chain Analysis
11.4 Lanreotide Market Dynamics
11.4.1 Lanreotide Industry Trends
11.4.2 Lanreotide Market Drivers
11.4.3 Lanreotide Market Challenges
11.4.4 Lanreotide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Lanreotide Distributors
12.3 Lanreotide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
